Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial

Summary

The aim of this study is to directly compare the bone forming effects of 20 microg/day of teriparatide with those of 2 g/day strontium ranelate as measured by the histomorphometric variables and biochemical bone formation markers after 6 months of therapy in postmenopausal women with osteoporosis.

Timeline

Start

2005-09

Primary completion

—

Completion

2007-01

Drugs

Indications